Seoul National University Hospital, Clinical Trial Center
Seoul, 110-744, South Korea
NCT Number: NCT01725620
To compare the pharmacokinetic characteristic of LBEC0101 25mg with active comparator, Enbrel® 25mg.
Looking for future studies?
Notify Me20 year–45 year
Male
Interventional
Phase 1
Seoul, 110-744, South Korea
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
LG Life Sciences
Industry
A Randomized, Double-blind, Single-dosing, 2-way Cross-over Study to Compate the Safety and Pharmacokinetic Characteristics of LBEC0101(Etanercept) 25mg With Those of Enbrel® 25mg After Subcutaneous Injection in Healthy Male Volunteers
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06945419
Body Weight, Body Weight Changes
Daytona Beach, Florida, United States
View Trial DetailsNCT05533372
Arthritis, Arthritis, Rheumatoid
Lenexa, Kansas, United States
View Trial DetailsNCT06916078
Digestive System Diseases, Healthy
Miami, Florida, United States
View Trial DetailsNCT05443438
Healthy
Stillwater, Oklahoma, United States
View Trial Details